BR0002424A - Concentrated ion zinc solutions - Google Patents
Concentrated ion zinc solutionsInfo
- Publication number
- BR0002424A BR0002424A BR0002424A BR0002424A BR0002424A BR 0002424 A BR0002424 A BR 0002424A BR 0002424 A BR0002424 A BR 0002424A BR 0002424 A BR0002424 A BR 0002424A BR 0002424 A BR0002424 A BR 0002424A
- Authority
- BR
- Brazil
- Prior art keywords
- zinc
- glycine
- zinc oxide
- solutions
- concentrated
- Prior art date
Links
Abstract
Patente de Invenção: "SOLUçõES CONCENTRADAS DE ZINCO IÈNICO". A invenção refere-se a soluções aquosas altamente concentradas de zinco catiónico e métodos de produção são revelados. Glicina aumenta grandemente a solubilidade de óxido de zinco em água. Quando aproximadamente de 2 a 20 equivalentes de glicina em relação a óxido de zinco são incluídos, concentrações de zinco de até aproximadamente 1,8 mol por litro são obtidas. Em uso, óxido de zinco é combinado com glicina e dissolvido em água sob aquecimento. Opcionalmente, óxido de zinco e glicina são pré-ativados através de moagem desses componentes juntamente, de preferência com uma proporção menor de água antes de dissolução. Uma proporção menor de uma quantidade medicamente útil de um sal de cobre pode também ser adicionada. As soluções concentradas de zinco são úteis, por exemplo, na produção de produtos farmacêuticos que contêm zinco, onde distribuição rápida e uniforme durante produção é benéfica.Invention Patent: "IONIC ZINC CONCENTRATED SOLUTIONS". The invention relates to highly concentrated aqueous solutions of cationic zinc and production methods are disclosed. Glycine greatly increases the solubility of zinc oxide in water. When approximately 2 to 20 equivalents of glycine relative to zinc oxide are included, zinc concentrations of up to approximately 1.8 mol per liter are obtained. In use, zinc oxide is combined with glycine and dissolved in water under heating. Optionally, zinc oxide and glycine are pre-activated by grinding these components together, preferably with a lower proportion of water before dissolving. A smaller proportion of a medically useful amount of a copper salt can also be added. Concentrated zinc solutions are useful, for example, in the production of pharmaceutical products that contain zinc, where rapid and uniform distribution during production is beneficial.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31318999A | 1999-05-18 | 1999-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0002424A true BR0002424A (en) | 2002-01-22 |
Family
ID=23214727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0002424A BR0002424A (en) | 1999-05-18 | 2000-05-17 | Concentrated ion zinc solutions |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BR0002424A (en) |
-
2000
- 2000-05-17 BR BR0002424A patent/BR0002424A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE294597T1 (en) | SOLUTION FOR PERITONEAL DIALYSIS | |
| FR2593823B1 (en) | PSEUDOPLASTIC ACID COMPOSITIONS FOR USE IN CLEANING SURFACES | |
| IL142876A0 (en) | Nano-emulsion of 5-aminolevulinic acid | |
| MY134521A (en) | Stable salts of o-acetylsalicylic acid with basic amino acids | |
| WO2007005633A8 (en) | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate | |
| PE20010400A1 (en) | COMMON SALT AND MOXIFLOXACIN FORMULATION | |
| MY130441A (en) | Solutions containing epinastin | |
| BR9905832A (en) | Chlorhexidine formulations, chlorhexidine salts, solutions containing these salts and their use | |
| DE3464849D1 (en) | Stable, aqueous, acidic solution of cis-platinum, suitable for injection | |
| RU97113465A (en) | Injection or Infusion Solutions of Enrofloxacin | |
| MY131971A (en) | Formulation of substituted benzimidazoles | |
| BR0002424A (en) | Concentrated ion zinc solutions | |
| IT1291291B1 (en) | USE OF HYALURONIC ACID AND RELATIVE SALTS FOR THE PREPARATION OF A WATER SOLUTION USEFUL AS INTRA-ARTICULAR WASHING LIQUID | |
| EP2145617A1 (en) | Gel formulation | |
| BRPI0115076B8 (en) | pharmaceutical preparation, its pharmaceutical application, as well as the process for its preparation | |
| MY144306A (en) | Aquoues solution of olanexidine, method of preparing the aqueous solution, and disinfectant | |
| JPS5762218A (en) | Ophthalmic solution | |
| JP2001107078A5 (en) | ||
| KR900009089A (en) | Alkatonin aqueous solution composition | |
| DE69313850D1 (en) | VETERINAER PRODUCT FOR REHYDRATION | |
| RU2002102309A (en) | Gel composition used in dentistry | |
| ES2181415T3 (en) | IONIC WATERY COMPOSITION CONTAINING LEVOMENTOL. | |
| CA2308660A1 (en) | Stable aqueous pharmaceutical composition comprising tezosentan | |
| BG104030U (en) | Formulation for the treatment of dermatomycoses | |
| JPH02145521A (en) | Stable eye drop |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Dismissal: definitive dismissal - article 33 of industrial property law |